Zenicor is leading in Europe within early diagnosis of arrhythmias and stroke prevention.
Zenicor is active in the Nordics, Germany, Switzerland, Austria, Cyprus and Great Britain. Zenicor’s customers consist of cardiology clinics, stroke clinics, medical clinics, paediatric clinics, clinical physiology clinics, private clinics, researchers within early diagnosis of arrhythmias and pharmaceutical companies as well as medical technology companies with interest in early diagnosis of arrhythmias.
The system is marketed directly to clinics by Zenicor´s own staff and also by local partners. In Great Britain Zenicor offers a complete service package to health care that in addition to product, service and support also includes interpretation of ECGs, which is provided through the partner Technomed Ltd. Further development of the system, training, technical support and service are primarily the tasks of the company’s own staff. Product manufacture is outsourced to the medtech-certified Swedish company Orbit One.
Zenicor is engaged in a close research partnership with leading researchers at Karolinska Institutet. Such partnerships have also been established in the rest of Zenicor´s international markets with research teams in the fields of stroke prevention and early detection of arrhythmias. There are currently more than 25 published studies in which Zenicor-ECG has been used and evaluated. Additionally, around 40 studies are in progress and is planned to be published during the coming years.